Complement-fixing donor-specific antibodies identified by a novel C1q assay are associated with allograft loss

Pediatric Transplantation

Volumn 16, Issue 1, 2012, Pages 12-17

  Sutherland, Scott M ^a   Chen, Ge ^b   Sequeira, Flavia A ^b   Lou, Calvin D ^b   Alexander, Steven R ^a   Tyan, Dolly B ^b  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b STANFORD UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

C1q; complement; donor specific antibody; pediatric; renal transplantation

Indexed keywords

COMPLEMENT COMPONENT C1Q ANTIBODY; COMPLEMENT COMPONENT C4D; COMPLEMENT FIXING ANTIBODY; DONOR SPECIFIC ANTIBODY; UNCLASSIFIED DRUG;

ACUTE GRAFT REJECTION; ADOLESCENT; ANTIBODY DETECTION; ANTIBODY PRODUCTION; ANTIBODY TITER; ARTICLE; C1Q SOLID PHASE ASSAY; CHILD; CLINICAL ARTICLE; COMPLEMENT DEPOSITION; COMPLEMENT FIXATION; DISEASE ASSOCIATION; FEMALE; HUMAN; KIDNEY DONOR; KIDNEY FAILURE; MALE;

ADOLESCENT; BIOPSY; CHILD; CHILD, PRESCHOOL; COMPLEMENT ACTIVATION; COMPLEMENT C1Q; COMPLEMENT FIXATION TESTS; FEMALE; GRAFT REJECTION; HUMANS; IMMUNOGLOBULIN G; KIDNEY TRANSPLANTATION; MALE; RENAL INSUFFICIENCY; RETROSPECTIVE STUDIES; TRANSPLANTATION, HOMOLOGOUS; TREATMENT OUTCOME;

EID: 84855992990     PISSN: 13973142     EISSN: 13993046     Source Type: Journal    
DOI: 10.1111/j.1399-3046.2011.01599.x     Document Type: Article

References (25)

1. 2008 Annual Report of the U.S. Organ Procurement and Transplantation Network and the Scientific Registry of Transplant Recipients: Transplant Data 1998-2007. Rockville, MD: Department of Health and Human Services, Health Resources and Services Administration, Healthcare Systems Bureau, Division of Transplantation; Richmond, VA: United Network for Organ Sharing; Ann Arbor, MI: University Renal Research and Education Association.
2. Seveso M, Bosio E, Ancona E, Cozzi E,. De novo anti-HLA antibody responses after renal transplantation: Detection and clinical impact. Contrib Nephrol 2009: 162: 87-98.
3. Terasaki P,. Humoral theory of transplantation. Am J Transplant 2003: 3: 665-673. (Pubitemid 36745238)
4. Terasaki P, Ozawa M,. Predictive value of HLA antibodies and serum creatinine in chronic rejection: Results of a 2-year prospective trial. Transplantation 2005: 80: 1194-1197. (Pubitemid 41746796)
5. Terasaki PI, Ozawa M, Castro R,. Four-year follow-up of a prospective trial of HLA and MICA antibodies on kidney graft survival. Am J Transplant 2007: 7: 408-415. (Pubitemid 46096334)
6. Halloran PF, Schlaut J, Solez K, Srinivasa NS,. The significance of the anti-class I response. II. Clinical and pathologic features of renal transplants with anti-class I-like antibody. Transplantation 1992: 53: 550-555.
7. Hourmant M, Cesbron-Gautier A, Terasaki PI, et al., Frequency and clinical implications of development of donor-specific and non-donor-specific HLA antibodies after kidney transplantation. J Am Soc Nephrol 2005: 16: 2804-2812.
8. Patel R, Terasaki PI,. Significance of the positive crossmatch test in kidney transplantation. N Engl J Med 1969: 280: 735-739.
9. Wahrmann M, Bartel G, Exner M, et al., Clinical relevance of preformed C4d-fixing and non-C4d-fixing HLA single antigen reactivity in renal allograft recipients. Transpl Int 2009: 22: 982-989.
10. Wahrmann M, Exner M, Schillinger M, et al., Pivotal role of complement-fixing HLA alloantibodies in presensitized kidney allograft recipients. Am J Transplant 2006: 6: 1033-1041. (Pubitemid 44356655)
11. Kishore U, Reid KB,. C1q: Structure, function, and receptors. Immunopharmacology 2000: 49: 159-170. (Pubitemid 30445227)
12. Walport MJ,. Complement-First of two parts. N Engl J Med 2001: 344: 1058-1066.
13. Walport MJ,. Complement-Second of two parts. N Engl J Med 2001: 344: 1140-1144.
14. Sarwal MM, Yorgin PD, Alexander S, et al., Promising early outcomes with a novel, complete steroid avoidance immunosuppression protocol in pediatric renal transplantation. Transplantation 2001: 72: 13-21. (Pubitemid 32652500)
15. Sarwal M, Vidhun J, Alexander S, Satterwhite T, Millan M, Salvatierra O,. Continued superior outcomes with modification and lengthened follow-up of a steroid-avoidance pilot with extended daclizumab induction in pediatric renal transplantation. Transplantation 2003: 76: 1331-1339. (Pubitemid 37430720)
16. Li L, Chang A, Naesens M, et al., Steroid-free immunosuppression since 1999: 129 pediatric renal transplants with sustained graft and patient benefits. Am J Transplant 2009: 9: 1362-1372.
17. Racusen LC, Solez K, Colvin RB, et al., The Banff 97 working classification of renal allograft pathology. Kidney Int 1999: 55: 713-723. (Pubitemid 29082898)
18. Solez K, Colvin RB, Racusen LC, et al., Banff 07 classification of renal allograft pathology: Updates and future directions. Am J Transplant 2008: 8: 753-760. (Pubitemid 351347767)
19. Wahrmann M, Exner M, Haidbauer B, et al., [C4d]FlowPRA screening-A specific assay for selective detection of complement-activating anti-HLA alloantibodies. Hum Immunol 2005: 66: 526-534. (Pubitemid 40797551)
20. Bartel G, Wahrmann M, Exner M, et al., In vitro detection of C4d-fixing HLA alloantibodies: Associations with capillary C4d deposition in kidney allografts. Am J Transplant 2008: 8: 41-49.
21. Chin C, Chen G, Sequeria F, et al., Clinical usefulness of a novel C1q assay to detect immunoglobulin G antibodies capable of fixing complement in sensitized pediatric heart transplant patients. J Heart Lung Transplant 2011: 30: 158-163.
22. Yabu J, Higgins J, Chen G, Sequeira F, Busque S, Tyan D,. C1q-fixing human leukocyte antigen antibodies are specific for predicting transplant glomerulopathy and late graft failure after kidney transplantation. Transplantation 2011: 91: 342-347.
23. Hönger G, Wahrmann M, Amico P, Hopfer H, Bhmig G, Schaub S,. C4d-fixing capability of low-level donor-specific HLA antibodies is not predictive for early antibody-mediated rejection. Transplantation 2010: 89: 1471-1475.
24. Bartel G, Wahrmann M, Exner M, et al., Determinants of the complement-fixing ability of recipient presensitization against HLA antigens. Transplantation 2007: 83: 727-733. (Pubitemid 46569190)
25. Smith JD, Hamour IM, Banner NR, Rose ML,. C4d fixing, luminex binding antibodies-A new tool for prediction of graft failure after heart transplantation. Am J Transplant 2007: 7: 2809-2815. (Pubitemid 350045767)